نتائج البحث 181-190 من 17258 لعملية البحث عن SDLD algorithm in personalized medicine site:nih.gov
The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't approved by the U.S. Food and Drug Administration (FDA). However, ...
To access residual muscle specimens from diagnostic muscle biopsies obtained as part of the routine medical care. The biospecimens will be used to better ...
Subjects in the Biobank will provide samples of excess breast tissue, complete a health questionnaire, and allow access to medical records now and in the future ...
JAMA Oncology. 2017; doi:10.1001/jamaoncol.2017.0424. Precision medicine initiative cohort program biobank. NIH RePORTER. https://reporter.nih.gov/search/ ...
Research is instrumental for improving medical care and the patient experience. Finding new surgical techniques can create better outcomes and minimize recovery ...
In this study, we make and test preclinical models of gynecological cancers (ovarian, fallopian tube, peritoneal, uterine, vulvar, cervix, and vaginal) of any ...
ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...
The purpose of this study is to learn if the study drug, [225Ac]Ac-PSMA-R2, is safe and tolerable, and has anti-tumor activity in treated patients. A Registry ...
The purpose of this study is to validate novel echocardiographic parameters and algorithms ... COVID-19 (Coronavirus) Pandemic on Health and Healthcare. Rochester ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.